Literature DB >> 11333889

Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus.

J Köck1, M Nassal, S MacNelly, T F Baumert, H E Blum, F von Weizsäcker.   

Abstract

The Asian tree shrew, Tupaia belangeri, has been proposed as a novel animal model for studying hepatitis B virus (HBV) infection. Here, we describe a protocol for efficient and reproducible infection of primary tupaia hepatocytes with HBV. We report that human serum interferes with HBV binding to the hepatocytes, thus limiting the maximum multiplicity of infection. Purification of HBV virions by gradient sedimentation greatly enhances virus binding and infectivity. Covalently closed circular DNA was clearly detectable by Southern blot analysis and newly synthesized single-stranded HBV DNA was visible 2 weeks postinoculation. Primary tupaia hepatocytes are also susceptible to infection with the recently discovered woolly monkey hepatitis B virus (WMHBV) but not to woodchuck hepatitis virus infection. Compared to HBV, WMHBV replicated at a higher rate with single-stranded DNA detectable within the first week postinoculation. Primary tupaia hepatocytes should represent a useful system for studying early steps of HBV and WMHBV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333889      PMCID: PMC114913          DOI: 10.1128/JVI.75.11.5084-5089.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks.

Authors:  J Summers; J M Smolec; R Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

Review 2.  Clinical aspects of hepatitis B virus infection.

Authors:  T L Wright; J Y Lau
Journal:  Lancet       Date:  1993-11-27       Impact factor: 79.321

3.  In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus.

Authors:  C E Aldrich; L Coates; T T Wu; J Newbold; B C Tennant; J Summers; C Seeger; W S Mason
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

4.  Purification of biologically active Epstein-Barr virus by affinity chromatography and non-ionic density gradient centrifugation.

Authors:  E Fowler; N Raab-Traub; S Hester
Journal:  J Virol Methods       Date:  1985-05       Impact factor: 2.014

5.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.

Authors:  J S Tuttleman; C Pourcel; J Summers
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

Review 6.  Mammalian phylogeny: shaking the tree.

Authors:  M J Novacek
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

7.  Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus.

Authors:  R Q Yan; J J Su; D R Huang; Y C Gan; C Yang; G H Huang
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

8.  Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration.

Authors:  P Gripon; C Diot; C Guguen-Guillouzo
Journal:  Virology       Date:  1993-02       Impact factor: 3.616

Review 9.  Hepatitis B virus replication.

Authors:  M Nassal; H Schaller
Journal:  Trends Microbiol       Date:  1993-09       Impact factor: 17.079

10.  In vitro experimental infection of primary human hepatocytes with hepatitis B virus.

Authors:  P R Galle; J Hagelstein; B Kommerell; M Volkmann; P Schranz; H Zentgraf
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

View more
  53 in total

1.  Re-evaluation and in silico annotation of the Tupaia herpesvirus proteins.

Authors:  Udo Bahr; Gholamreza Darai
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

2.  Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees.

Authors:  Pei Zhang; Mei-Ying W Yu; Richard Venable; Harvey J Alter; J Wai-Kou Shih
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

Review 3.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 4.  Hepatitis B virus replication.

Authors:  Juergen Beck; Michael Nassal
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Authors:  Xiping Zhao; Zhen-Ya Tang; Bettina Klumpp; Guido Wolff-Vorbeck; Heidi Barth; Shoshana Levy; Fritz von Weizsäcker; Hubert E Blum; Thomas F Baumert
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

6.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

Review 7.  Is hepatitis B-virucidal validation of biocides possible with the use of surrogates?

Authors:  Andreas Sauerbrei
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

8.  Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.

Authors:  Dieter Glebe; Mehriar Aliakbari; Peter Krass; Eva V Knoop; Klaus P Valerius; Wolfram H Gerlich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Molecular anatomy of Tupaia (tree shrew) adenovirus genome; evolution of viral genes and viral phylogeny.

Authors:  Udo Bahr; Eva Schöndorf; Michaela Handermann; Gholamreza Darai
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

10.  Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes.

Authors:  Guocai Zhong; Huan Yan; Haimin Wang; Wenhui He; Zhiyi Jing; Yonghe Qi; Liran Fu; Zhenchao Gao; Yi Huang; Guangwei Xu; Xiaofeng Feng; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.